Usher Institute 1

1. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
2. Management of anaphylaxis due to COVID-19 vaccines in the elderly
3. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
4. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
5. Advancing the global public health agenda for NAFLD: a consensus statement
6. Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021
7. Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference
8. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study
9. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
1